Biblio

L. R. Brunham, Kang, M. H., Van Karnebeek, C., Sadananda, S. N., Collins, J. A., Zhang, L. - H., Sayson, B., Miao, F., Stockler, S., Frohlich, J., Cassiman, D., Rabkin, S. W., and Hayden, M. R., “Clinical, Biochemical, and Molecular Characterization of Novel Mutations in ABCA1 in Families with Tangier Disease.”, JIMD Rep, vol. 18, pp. 51-62, 2015.

S. M. Dimick, Sallee, B., Asztalos, B. F., P Pritchard, H., Frohlich, J., and Schaefer, E. J., “A kindred with fish eye disease, corneal opacities, marked high-density lipoprotein deficiency, and statin therapy.”, J Clin Lipidol, vol. 8, no. 2, pp. 223-30, 2014.

M. D. Allard, Saeedi, R., Yousefi, M., and Frohlich, J., “Risk stratification of patients with familial hypercholesterolemia in a multi-ethnic cohort.”, Lipids Health Dis, vol. 13, p. 65, 2014.

J. Frohlich and Al-Sarraf, A., “Cardiovascular risk and atherosclerosis prevention.”, Cardiovasc Pathol, vol. 22, no. 1, pp. 16-8, 2013.

G. B. John Mancini, A Tashakkor, Y., Baker, S., Bergeron, J., Fitchett, D., Frohlich, J., Genest, J., Gupta, M., Hegele, R. A., Ng, D. S., Pearson, G. J., and Pope, J., “Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Working Group Consensus update.”, Can J Cardiol, vol. 29, no. 12, pp. 1553-68, 2013.

J. Frohlich and Al-Sarraf, A., “Cholesterol efflux capacity and atherosclerosis.”, N Engl J Med, vol. 364, no. 15, pp. 1474; author reply 1474-5, 2011.

M. Dobiásová, Frohlich, J., Sedová, M., Cheung, M. C., and B Brown, G., “Cholesterol esterification and atherogenic index of plasma correlate with lipoprotein size and findings on coronary angiography.”, J Lipid Res, vol. 52, no. 3, pp. 566-71, 2011.

J. Hill, Heslop, C., Man, S. F. Paul, Frohlich, J., Connett, J. E., Anthonisen, N. R., Wise, R. A., Tashkin, D. P., and Sin, D. D., “Circulating surfactant protein-D and the risk of cardiovascular morbidity and mortality.”, Eur Heart J, vol. 32, no. 15, pp. 1918-25, 2011.

D. J. A. Jenkins, Jones, P. J. H., Lamarche, B., Kendall, C. W. C., Faulkner, D., Cermakova, L., Gigleux, I., Ramprasath, V., de Souza, R., Ireland, C., Patel, D., Srichaikul, K., Abdulnour, S., Bashyam, B., Collier, C., Hoshizaki, S., Josse, R. G., Leiter, L. A., Connelly, P. W., and Frohlich, J., “Effect of a dietary portfolio of cholesterol-lowering foods given at 2 levels of intensity of dietary advice on serum lipids in hyperlipidemia: a randomized controlled trial.”, JAMA, vol. 306, no. 8, pp. 831-9, 2011.

M. Li, Al-Sarraf, A., Sinclair, G., and Frohlich, J., “Fish odour syndrome.”, CMAJ, vol. 183, no. 8, pp. 929-31, 2011.

S. Sandhu, Al-Sarraf, A., Taraboanta, C., Frohlich, J., and Francis, G. A., “Incidence of pancreatitis, secondary causes, and treatment of patients referred to a specialty lipid clinic with severe hypertriglyceridemia: a retrospective cohort study.”, Lipids Health Dis, vol. 10, p. 157, 2011.

G. B. John Mancini and Frohlich, J., “Carotid ultrasound, coronary calcium, and dyslipidemia patterns in the MESA (Multi-Ethnic Study of Atherosclerosis) cohort.”, J Am Coll Cardiol, vol. 56, no. 13, pp. 1042-4, 2010.

J. Genest, McPherson, R., Frohlich, J., Anderson, T., Campbell, N., Carpentier, A., Couture, P., Dufour, R., Fodor, G., Francis, G. A., Grover, S., Gupta, M., Hegele, R. A., Lau, D. C., Leiter, L., Lewis, G. F., Lonn, E., Mancini, G. B. John, Ng, D., Pearson, G. J., Sniderman, A., Stone, J. A., and Ur, E., “2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations.”, Can J Cardiol, vol. 25, no. 10, pp. 567-79, 2009.

D. T. Holmes, Schick, B. A., Humphries, K. H., and Frohlich, J., “Lipoprotein(a) is an independent risk factor for cardiovascular disease in heterozygous familial hypercholesterolemia.”, Clin Chem, vol. 51, no. 11, pp. 2067-73, 2005.